Stockreport

Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF B2 receptor antagonists to prevent and treat hereditary angioedema (HAE) attacks, today announced that its management will participate in the Inaugural Guggenheim Securi [Read more]